Related Experiment Videos
[Hydrogel, a new galenic form in ophthalmology]
1Pharmazeutisches Institut ETH Zürich, Abt. Galenik.
Klinische Monatsblatter Fur Augenheilkunde
|May 1, 1990
Summary
Viscous eye drops, or hydrogels, offer good tolerance and long application intervals for treating bacterial eye infections. Fusidic acid hydrogel provides sustained antibiotic levels, improving patient compliance with twice-daily application.
Area of Science:
- Ophthalmology
- Pharmacology
- Drug Delivery Systems
Background:
- Bacterial eye infections require effective and sustained antibiotic treatment.
- Traditional eye drop formulations may suffer from short retention times and poor patient compliance.
- Hydrogels offer unique properties for ophthalmic drug delivery.
Purpose of the Study:
- To evaluate fusidic acid in a hydrogel formulation for bacterial eye infections.
- To assess the pharmacokinetic profile and clinical efficacy of the hydrogel.
- To determine the impact on patient compliance.
Main Methods:
- Development of a viscous eye drop (hydrogel) formulation containing fusidic acid.
- Administration of the hydrogel twice daily to patients with bacterial eye infections.
- Monitoring of antibiotic concentration in tear fluid and ocular tissues.
- Assessment of drug tolerance and patient compliance.
Main Results:
- The hydrogel formulation demonstrated good tolerance and excellent adhesion.
- Sustained concentrations of fusidic acid were achieved in tear fluid.
- Twice-daily application ensured sufficient antibiotic levels in key ocular tissues.
- Increased patient compliance was observed compared to conventional treatments.
Conclusions:
- Fusidic acid hydrogel is a well-tolerated and effective treatment for bacterial eye infections.
- The hydrogel formulation provides prolonged antibiotic presence, enhancing therapeutic outcomes.
- This delivery system improves patient compliance through convenient dosing intervals.